N-Myc和STAT交互剂是一种子宫内膜异位症抑制剂
bioRxiv : the preprint server for biology
|May 20, 2024
概括
N-Myc和STAT交互剂 (NMI) 通过增强免疫细胞死亡和抑制子宫内膜细胞生长来抑制子宫内膜症. 降低子宫内膜异位症病变中的NMI水平促进了病变的发展,突出显示了NMI作为潜在的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 生殖医学 生殖医学
背景情况:
- 子宫内膜异位症涉及子宫内膜片段逃避免疫监测形成病变.
- 在子宫内膜异位症中免疫逃避的机制尚未完全理解.
- N-Myc和STAT交互体 (NMI) 对于干扰素 (IFN) 诱导的免疫细胞死亡途径至关重要.
研究的目的:
- 调查NMI在子宫内膜异位症免疫规避中的作用.
- 阐明NMI影响子宫内膜细胞行为的机制.
- 为了确定NMI是否在子宫内膜异位症中起到瘤抑制作用.
主要方法:
- 在人类子宫内膜病变中分析NMI水平.
- 在不朽化的人类子宫内膜层细胞 (IHESCs) 中击败NMI.
- 用干扰素-α (IFNA) 治疗细胞并评估信号通路.
- 在NMI敲击后评估小鼠子宫内膜异位症模型中的病变生长.
主要成果:
- 在子宫内膜层细胞中,NMI水平通过雌激素受体β/基因组脱乙酶8轴降低.
- 在IHESC中,NMI的淘汰改变了与细胞粘附和细胞外基因相关的基因.
- 在IFNA治疗后,NMI倒置抑制了亡和亡,但激活了增殖途径 (β-Catenin,AKT).
- 在小鼠模型中,NMI knockdown刺激了宫外病变的生长.
结论:
- 尼米作为子宫内膜异位症的抑制剂.
- 在IFN暴露后,NMI增强了细胞亡,并抑制了子宫内膜细胞的增殖和细胞粘附.
- 对于子宫内膜异位症治疗来说,NMI是一个潜在的治疗点.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K


